Sign in
Explore the registryTrack Empagliflozin's trials

Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2)

EmpagliflozinCompletedCompletedPhase 3Open NCT02414958 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…